Roivant Sciences Director Ilan Oren Receives Annual Equity Grant
Roivant Sciences Ltd.
Subscribe to track ROIV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Roivant Sciences Ltd. ($ROIV) — Form 4 Filing Update
Insider: Ilan Oren (Director) Transaction Date: October 23, 2026 Type: Award / Grant (Code: A) Shares Acquired: 810 common shares @ $0.00 Total Value: $0.00 Post-Transaction Holdings: 124,490 shares (Direct)
Note: Award received pursuant to the Non-Employee Director Compensation Plan, fully vested on grant date.
Comprehensive Analysis
Executive Summary
On October 27, 2026, Roivant Sciences Ltd. ($ROIV) filed a Form 4 detailing an equity grant to Director Ilan Oren. On October 23, 2026, Oren received an award of 810 Common Shares at $0.00 per share under the company's Non-Employee Director Compensation Plan. Following the transaction, Oren directly holds 124,490 common shares.
Transaction Details
- Reporting Owner: Ilan Oren
- Role: Director
- Transaction Code: A (Grant, award, or other acquisition)
- Shares Acquired: 810 Common Shares
- Price per Share: $0.00
- Transaction Value: $0.00
- Post-Transaction Direct Ownership: 124,490 Common Shares
Market and Trading Impact
This filing represents routine non-employee director compensation that vested immediately upon grant. Because it is a predetermined compensation award rather than an open-market purchase or disposition, it carries low trading significance and provides no direct directional signal regarding company performance or sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.